We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

PURITAN MEDICAL

Puritan Medical Products is a manufacturer of healthcare, diagnostic and critical environment products. Its portfolio... read more Featured Products: More products

Download Mobile App





Puritan Medical Exhibits Its World-Renowned Swabs and Other Product Offerings

By LabMedica International staff writers
Posted on 22 Jul 2023
Print article
Image: Puritan is introducing its product offerings to global experts and potential customers at AACC 2023 (Photo courtesy of Puritan)
Image: Puritan is introducing its product offerings to global experts and potential customers at AACC 2023 (Photo courtesy of Puritan)

Puritan Medical Products (Guilford, ME, USA), the world's most trusted manufacturer of swabs, is attending AACC 2023 where the company is exhibiting its world-renowned swabs and other products. Puritan is also demonstrating its expertise in topics such as automation, pandemic response, and virus protection, participating in panel discussions, joining in-depth symposiums, and introducing its various experts to their global counterparts.

Prior to AACC 2023, Puritan attended ASM Microbe 2023 hosted in June in Houston, Texas by the American Society for Microbiology. During the event, which is the largest microbial sciences gathering in the world, Puritan highlighted its key business lines—and core product offerings—to thousands of scientists, researchers, and healthcare professionals who are at the forefront of medical advancement. At the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo, hosted by the American Association for Clinical Chemistry, Puritan is exhibiting its products and solutions at Booth #4115. Puritan is playing a pivotal part in exploring the cutting-edge science and technology that are shaping the future of laboratory medicine, with the event featuring more than 800 exhibitors and over 200 new products and services.

Puritan works hand-in-hand with its customers to create the best single-use products for reliable specimen collection and accurate diagnoses. By combining user feedback and a proprietary research manufacturing process, the company has developed a patented, intricate fiber technology that provides the highest collection and elution capacities available on the market. The company’s patented HydraFlock and PurFlock Ultra flocked swabs are made with intricate, multi-length fibers for superior specimen collection and elution. Ultimate purity and efficient cell release characteristics make PurFlock Ultra flocked swabs ideal for PCR, molecular assays, rapid tests, and forensic applications. Designed specifically for the collection of biological specimens, HydraFlock provides higher absorption capacity and complete elution. Puritan also offers dry as well as media-filled transport systems.

“Puritan has a unique opportunity to expand its international presence while also connecting with existing customers, explaining why our unique approach to customization is applicable to a wide range of industries,” said Bob Shultz, President and CFO at Puritan. “From California to Texas and other countries, Puritan changes the world for the better on a daily basis, and we couldn't be prouder to share that story with others.”

Related Links:
Puritan Medical Products 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Orienta Tsutsugamushi Test
STANDARD Q Tsutsugamushi IgM/IgG
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.